Integra Historical Valuation

IART Stock  USD 12.56  0.25  2.03%   
Some fundamental drivers such as market cap or Integra LifeSciences enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Integra LifeSciences valuation indicators such as Enterprise Value of 442.9 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Integra LifeSciences's future value.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integra LifeSciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Integra Valuation Data Analysis

Valuation is the financial process of determining what Integra LifeSciences is worth. Integra LifeSciences valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Integra LifeSciences valuation ratios help investors to determine whether Integra Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Integra with respect to the benefits of owning Integra LifeSciences security.

Integra LifeSciences Valuation Data Chart

Market Cap is likely to gain to about 1 B in 2025. Enterprise Value is likely to gain to about 442.9 M in 2025

Enterprise Value

Enterprise Value (or EV) is usually referred to as Integra LifeSciences theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Integra LifeSciences debt, but would also pocket its cash. Enterprise Value is more accurate representation of Integra LifeSciences value than its market capitalization because it takes into account all of Integra LifeSciences Holdings existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Integra Stock Analysis

When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.